Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations

Campylobacter infections are a prevalent cause of diarrheal disease in humans and are the most significant zoonotic pathogens worldwide. Human campylobacteriosis is generally via ingestion of contaminated poultry products. However, based on recent studies chicken egg yolk antibody (IgY) powder has g...

Full description

Saved in:
Bibliographic Details
Main Authors: Nazanin Soltani, Shaban Rahimi, Pejvak Khaki, Mohammad Amir Karimi Torshizi, Bahareh Eskandari, Jesse Grimes
Format: Article
Language:English
Published: Elsevier 2025-02-01
Series:Poultry Science
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0032579124012963
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553882427162624
author Nazanin Soltani
Shaban Rahimi
Pejvak Khaki
Mohammad Amir Karimi Torshizi
Bahareh Eskandari
Jesse Grimes
author_facet Nazanin Soltani
Shaban Rahimi
Pejvak Khaki
Mohammad Amir Karimi Torshizi
Bahareh Eskandari
Jesse Grimes
author_sort Nazanin Soltani
collection DOAJ
description Campylobacter infections are a prevalent cause of diarrheal disease in humans and are the most significant zoonotic pathogens worldwide. Human campylobacteriosis is generally via ingestion of contaminated poultry products. However, based on recent studies chicken egg yolk antibody (IgY) powder has great potential to reduce the cecum load of Campylobacter jejuni (C. jejuni) in broilers. To understand the effective and economically feasible dosage, two immunization and challenge studies were conducted using 30 layer hens and 250 broiler chickens and found a scientific approach, starting with in vitro evaluations and progressing with in vivo studies confirmed. In this study it was demonstrated that specific IgY powder (SIgY), produced by immunized hens via bacterin, was highly effective in inhibiting bacterial growth and adhesion, as well as exhibiting bactericidal and agglutination properties (P < 0.05). Notably, doses of 0.5 % and 1 % SIgY significantly enhanced both the height and width of intestinal villi, along with improving the villus height-to-crypt depth ratio when compared to the positive control group (P < 0.05). Furthermore, medium and high doses of SIgY were effective in preserving the integrity of the intestinal epithelium, as evidenced by a reduction in crypt depth and the number of goblet cells, which serve as important markers in the immune system (P < 0.01). Additionally, analyses of cecal and liver bacterial counts in response to the 0.5 % SIgY treatment revealed a significant reduction in C. jejuni counts compared to other challenged groups throughout the 28 d experiment (P < 0.01). Based on these results, it may be concluded that specific antibodies play a crucial role in maintaining the integrity of intestinal villi, support the health of the intestinal epithelium, and reduce the colonization of C. jejuni. These findings could form the basis for developing an economical and effective strategy to enhance poultry and human health in the context of C. jejuni infection.
format Article
id doaj-art-4496a6243fa343c8a09ef6d2fe68d8ee
institution Kabale University
issn 0032-5791
language English
publishDate 2025-02-01
publisher Elsevier
record_format Article
series Poultry Science
spelling doaj-art-4496a6243fa343c8a09ef6d2fe68d8ee2025-01-09T06:12:09ZengElsevierPoultry Science0032-57912025-02-011042104718Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluationsNazanin Soltani0Shaban Rahimi1Pejvak Khaki2Mohammad Amir Karimi Torshizi3Bahareh Eskandari4Jesse Grimes5Department of Poultry Science, Faculty of Agriculture, Tarbiat Modares University, Postal code: 1411713116, Tehran, IranDepartment of Poultry Science, Faculty of Agriculture, Tarbiat Modares University, Postal code: 1411713116, Tehran, IranDepartment of Microbiology, Razi Vaccine and Serum Production Research Institute, Agricultural Research, Education and Extension Organization (AREEO), Postal Code: 3197619751, Karaj, IranDepartment of Poultry Science, Faculty of Agriculture, Tarbiat Modares University, Postal code: 1411713116, Tehran, IranDepartment of Poultry Science, Faculty of Agriculture, Tarbiat Modares University, Postal code: 1411713116, Tehran, IranPrestage Department of Poultry Science, College of Agriculture and Life Sciences, North Carolina State University, Raleigh, NC 27695-7608; Corresponding author.Campylobacter infections are a prevalent cause of diarrheal disease in humans and are the most significant zoonotic pathogens worldwide. Human campylobacteriosis is generally via ingestion of contaminated poultry products. However, based on recent studies chicken egg yolk antibody (IgY) powder has great potential to reduce the cecum load of Campylobacter jejuni (C. jejuni) in broilers. To understand the effective and economically feasible dosage, two immunization and challenge studies were conducted using 30 layer hens and 250 broiler chickens and found a scientific approach, starting with in vitro evaluations and progressing with in vivo studies confirmed. In this study it was demonstrated that specific IgY powder (SIgY), produced by immunized hens via bacterin, was highly effective in inhibiting bacterial growth and adhesion, as well as exhibiting bactericidal and agglutination properties (P < 0.05). Notably, doses of 0.5 % and 1 % SIgY significantly enhanced both the height and width of intestinal villi, along with improving the villus height-to-crypt depth ratio when compared to the positive control group (P < 0.05). Furthermore, medium and high doses of SIgY were effective in preserving the integrity of the intestinal epithelium, as evidenced by a reduction in crypt depth and the number of goblet cells, which serve as important markers in the immune system (P < 0.01). Additionally, analyses of cecal and liver bacterial counts in response to the 0.5 % SIgY treatment revealed a significant reduction in C. jejuni counts compared to other challenged groups throughout the 28 d experiment (P < 0.01). Based on these results, it may be concluded that specific antibodies play a crucial role in maintaining the integrity of intestinal villi, support the health of the intestinal epithelium, and reduce the colonization of C. jejuni. These findings could form the basis for developing an economical and effective strategy to enhance poultry and human health in the context of C. jejuni infection.http://www.sciencedirect.com/science/article/pii/S0032579124012963BacterinBroiler chickenCampylobacter jejuniEgg yolk immunoglobulins
spellingShingle Nazanin Soltani
Shaban Rahimi
Pejvak Khaki
Mohammad Amir Karimi Torshizi
Bahareh Eskandari
Jesse Grimes
Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations
Poultry Science
Bacterin
Broiler chicken
Campylobacter jejuni
Egg yolk immunoglobulins
title Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations
title_full Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations
title_fullStr Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations
title_full_unstemmed Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations
title_short Efficacy of hyperimmunized egg yolk antibodies (IgY) against Campylobacter jejuni: In Vitro and In Vivo evaluations
title_sort efficacy of hyperimmunized egg yolk antibodies igy against campylobacter jejuni in vitro and in vivo evaluations
topic Bacterin
Broiler chicken
Campylobacter jejuni
Egg yolk immunoglobulins
url http://www.sciencedirect.com/science/article/pii/S0032579124012963
work_keys_str_mv AT nazaninsoltani efficacyofhyperimmunizedeggyolkantibodiesigyagainstcampylobacterjejuniinvitroandinvivoevaluations
AT shabanrahimi efficacyofhyperimmunizedeggyolkantibodiesigyagainstcampylobacterjejuniinvitroandinvivoevaluations
AT pejvakkhaki efficacyofhyperimmunizedeggyolkantibodiesigyagainstcampylobacterjejuniinvitroandinvivoevaluations
AT mohammadamirkarimitorshizi efficacyofhyperimmunizedeggyolkantibodiesigyagainstcampylobacterjejuniinvitroandinvivoevaluations
AT bahareheskandari efficacyofhyperimmunizedeggyolkantibodiesigyagainstcampylobacterjejuniinvitroandinvivoevaluations
AT jessegrimes efficacyofhyperimmunizedeggyolkantibodiesigyagainstcampylobacterjejuniinvitroandinvivoevaluations